Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer
Clinical trial NCT02167854 · COMPLETED
Trial details
- NCT number
- NCT02167854
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-16
- Primary completion
- 2021-07-07
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.